يعرض 1 - 20 نتائج من 311 نتيجة بحث عن '"Martin-fernandez, Marta"', وقت الاستعلام: 0.62s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المساهمون: Laboratoire de Bioingénierie et NanoSciences (LBN), Université de Montpellier (UM), Laboratoire Charles Coulomb (L2C), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CHU Montpellier = Montpellier University Hospital, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)

    المصدر: ISSN: 1661-6596.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/39201803; PUBMED: 39201803; PUBMEDCENTRAL: PMC11354632

  4. 4
    Academic Journal

    المساهمون: HUS Children and Adolescents, Children's Hospital, Clinicum

    وصف الملف: application/pdf

    Relation: The authors thank all the patients, their relatives and the treatment teams for their cooperation in this study. We also thank: all the members of the HGID laboratory for helpful discussions, Christine Rivalain, Lazaro Lorenzo-Diaz, Maya Chrabieh, Mark Woollet, Erin Williams, Dana Liu, and Yelena Nemirovskaya for administrative assistance. The INEM flow-cytometry facility, in particular Jerome Megret, for their support and services. We thank the National Institutes of Health Tetramer Core Facility for providing the MR1 tetramer, which was developed jointly with Dr. JamesMcCluskey, Dr. Jamie Rossjohn, and Dr. David Fairlie. Funding: the Laboratory of Human Genetics of Infectious Diseases was funded by the Howard Hughes Medical Institute, The Rockefeller University, the St. Giles Foundation, the National Institutes of Health (NIH) (R37AI095983), the National Center for Research Resources and the National Center for Advancing Sciences, NIH (UL1TR001866), the Shapiro-Silverberg Fund for the Advancement of Translational Research, the French Foundation for Medical Research (FRM) (EQU201903007798), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID), the French National Research Agency (ANR) under the “Investments for the future” program (ANR-10-IAHU-01), ANR-GENMSMD (ANR-16-CE17-0005-01), ANR-MAFMACRO (ANR-22-CE92- 0008), the European Union's Horizon 2020 research and innovation program under grant agreement no. 824110 (EASI-genomics), the Square Foundation, Grandir – Fonds de solidarité pour l'enfance, the SCOR Corporate Foundation for Science, Institut National de la Santé et de la Recherche Médicale (INSERM), and Paris Cité University. N.M. was supported by Sidra Medicine and the Qatar National Research Fund (grant no.: NPRP9-251-3-045). The Yale Center for Mendelian Genomics (UM1HG006504) was funded by the National Human Genome Research Institute, the Yale GSP Coordinating Center (U24 HG008956), and the Yale High-Performance Computing Center (S10OD018521). J.Bohlen was supported by a fellowship from EMBO and a Marie Curie Research grant. M.O. was supported by the David Rockefeller Graduate Program, the Funai Foundation for Information Technology (FFIT), the Honjo International Scholarship Foundation (HISF), the New York Hideyo Noguchi Memorial Society (HNMS). Q.P. was supported by the Assistance Publique – Hôpitaux de Paris (research year) and the MD-PhD program of Inserm (Ecole de l'Inserm Liliane Bettencourt). J.R. was supported by the Inserm PhD program for doctors of pharmacy (poste d'accueil Inserm). J.R. and T.L.-V. were supported by the Bettencourt-Schueller Foundation and the MD-PhD program of the Imagine Institute. A-L.N. was supported by the Bettencourt Schueller Foundation the International PhD program of the Imagine Institute and the Fondation pour la Recherche Médicale (FDT202204015102). Q. Zhou was supported by the “Outstanding Youth Talent Training Program” of the Children's Hospital of Fudan University. M. Momenilandi was supported by ANRS, Maladies infectieuses émergentes (ECTZ173053). J. Bohlen, J. Bustamante, Q. Zhang, and J.-L.C. conceived the study, designed the experiments, interpreted the data, and drafted the manuscript. J. Bohlen, Q. Zhou, Q. Zhang, C.C. Y.S. A.C. and L.A. analyzed WES data. J. Bohlen, Q. Zhou, M.R. Q.P. J.R. M.O. A.-L.N. C.A.A.F. A.S.L.H. L.E. J.E.H. C.Sc. C.So. T.L.-V. M.E. M.M. M.R. M.S. N.M. T.K. T.V. D.B. A.E. R.Y. A.Y. J. Peel, J. Puchan, M.M.-V. M.M.-F. F.S. V.B. S.B.-D. and Z.J. performed experiments and generated figures. S.S. E.S. M.A.-S. G.E.G. N.Y. T.N. S.H. M.S. N.P. N.R. X.W. Q. Zhang, and J. Bustamante recruited patients and coordinated the clinical study protocol and sample collection. J. Bohlen, M.O. P.Z. and D.R. analyzed RNA-seq experiments. S.B.-D. A.T. J-.L.C. Q. Zhang, and J. Bustamante supervised experiments or analyses. All the authors discussed, revised, and approved the manuscript. J.-L.C. serves on the scientific advisory boards of ADMA Biologics Inc. Kymera Therapeutics, and Elixiron Immunotherapeutics. The authors thank all the patients, their relatives and the treatment teams for their cooperation in this study. We also thank: all the members of the HGID laboratory for helpful discussions, Christine Rivalain, Lazaro Lorenzo-Diaz, Maya Chrabieh, Mark Woollet, Erin Williams, Dana Liu, and Yelena Nemirovskaya for administrative assistance. The INEM flow-cytometry facility, in particular Jerome Megret, for their support and services. We thank the National Institutes of Health Tetramer Core Facility for providing the MR1 tetramer, which was developed jointly with Dr. JamesMcCluskey, Dr. Jamie Rossjohn, and Dr. David Fairlie. Funding: the Laboratory of Human Genetics of Infectious Diseases was funded by the Howard Hughes Medical Institute , The Rockefeller University , the St. Giles Foundation , the National Institutes of Health (NIH) ( R37AI095983 ), the National Center for Research Resources and the National Center for Advancing Sciences , NIH ( UL1TR001866 ), the Shapiro-Silverberg Fund for the Advancement of Translational Research , the French Foundation for Medical Research (FRM) ( EQU201903007798 ), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence ( ANR-10-LABX-62-IBEID ), the French National Research Agency (ANR) under the “Investments for the future” program ( ANR-10-IAHU-01 ), ANR-GENMSMD ( ANR-16-CE17-0005-01 ), ANR-MAFMACRO ( ANR-22-CE92- 0008 ), the European Union’s Horizon 2020 research and innovation program under grant agreement no. 824110 (EASI-genomics), the Square Foundation , Grandir – Fonds de solidarité pour l’enfance , the SCOR Corporate Foundation for Science , Institut National de la Santé et de la Recherche Médicale (INSERM), and Paris Cité University . N.M. was supported by Sidra Medicine and the Qatar National Research Fund (grant no.: NPRP9-251-3-045 ). The Yale Center for Mendelian Genomics ( UM1HG006504 ) was funded by the National Human Genome Research Institute , the Yale GSP Coordinating Center ( U24 HG008956 ), and the Yale High-Performance Computing Center ( S10OD018521 ). J.Bohlen was supported by a fellowship from EMBO and a Marie Curie Research grant . M.O. was supported by the David Rockefeller Graduate Program , the Funai Foundation for Information Technology (FFIT), the Honjo International Scholarship Foundation (HISF), the New York Hideyo Noguchi Memorial Society (HNMS). Q.P. was supported by the Assistance Publique – Hôpitaux de Paris (research year) and the MD-PhD program of Inserm (Ecole de l’Inserm Liliane Bettencourt). J.R. was supported by the Inserm PhD program for doctors of pharmacy (poste d’accueil Inserm). J.R. and T.L.-V. were supported by the Bettencourt-Schueller Foundation and the MD-PhD program of the Imagine Institute . A-L.N. was supported by the Bettencourt Schueller Foundation the International PhD program of the Imagine Institute and the Fondation pour la Recherche Médicale ( FDT202204015102 ). Q. Zhou was supported by the “Outstanding Youth Talent Training Program” of the Children’s Hospital of Fudan University . M. Momenilandi was supported by ANRS, Maladies infectieuses émergentes ( ECTZ173053 ).; Bohlen , J , Zhou , Q , Philippot , Q , Ogishi , M , Rinchai , D , Nieminen , T , Seyedpour , S , Parvaneh , N , Rezaei , N , Yazdanpanah , N , Momenilandi , M , Conil , C , Neehus , A L , Schmidt , C , Arango-Franco , C A , Voyer , T L , Khan , T , Yang , R , Puchan , J , Erazo , L , Roiuk , M , Vatovec , T , Janda , Z , Bagarić , I , Materna , M , Gervais , A , Li , H , Rosain , J , Peel , J N , Seeleuthner , Y , Han , J E , L'Honneur , A S , Moncada-Vélez , M , Martin-Fernandez , M , Horesh , M E , Kochetkov , T , Schmidt , M , AlShehri , M A , Salo , E , Saxen , H , ElGhazali , G , Yatim , A , Soudée , C , Sallusto , F , Ensser , A , Marr , N , Zhang , P , Bogunovic , D , Cobat , A , Shahrooei , M , Béziat , V , Abel , L , Wang , X , Boisson-Dupuis , S , Teleman , A A , Bustamante , J , Zhang , Q & Casanova , J L 2023 , ' Human MCTS1-dependent translation of JAK2 is essential for IFN-γ immunity to mycobacteria ' , Cell , vol. 186 , no. 23 , pp. 5114-5134.e27 . https://doi.org/10.1016/j.cell.2023.09.024; http://hdl.handle.net/10138/576480; 16fa6ada-d995-455f-a559-9967c3819b6f; 85175701992; 001115514300001

  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
  9. 9
  10. 10
    Report
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
  15. 15
    Academic Journal

    المساهمون: Laboratoire de Bioingénierie et NanoSciences (LBN), Université de Montpellier (UM), CHU Montpellier, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institute of Biophysics, Biological Research Centre Budapest (BRC), Hungarian Academy of Sciences (MTA)-Hungarian Academy of Sciences (MTA), Laboratoire Charles Coulomb (L2C), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Medical University of Plovdiv, Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Hôpital Lapeyronie CHU Montpellier, الجامعة اللبنانية بيروت = Lebanese University Beirut = Université libanaise Beyrouth (LU / ULB)

    المصدر: ISSN: 2296-4185 ; Frontiers in Bioengineering and Biotechnology ; https://hal.science/hal-04139349 ; Frontiers in Bioengineering and Biotechnology, 2023, 11, pp.1165853. ⟨10.3389/fbioe.2023.1165853⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/37409165; PUBMED: 37409165; PUBMEDCENTRAL: PMC10318435

  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
  19. 19
    Academic Journal
  20. 20
    Academic Journal